Deregulated expression of Cdc6 in the skin facilitates papilloma formation and affects the hair growth cycle

Cdc6 encodes a key protein for DNA replication, responsible for the recruitment of the MCM helicase to replication origins during the G1 phase of the cell division cycle. The oncogenic potential of deregulated Cdc6 expression has been inferred from cellular studies, but no mouse models have been des...

Full description

Saved in:
Bibliographic Details
Published in:Cell cycle (Georgetown, Tex.) Vol. 14; no. 24; pp. 3897 - 3907
Main Authors: Búa, Sabela, Sotiropoulou, Peggy, Sgarlata, Cecilia, Borlado, Luis R, Eguren, Manuel, Domínguez, Orlando, Ortega, Sagrario, Malumbres, Marcos, Blanpain, Cedric, Méndez, Juan
Format: Journal Article
Language:English
Published: United States Taylor & Francis 01-01-2015
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Cdc6 encodes a key protein for DNA replication, responsible for the recruitment of the MCM helicase to replication origins during the G1 phase of the cell division cycle. The oncogenic potential of deregulated Cdc6 expression has been inferred from cellular studies, but no mouse models have been described to study its effects in mammalian tissues. Here we report the generation of K5-Cdc6, a transgenic mouse strain in which Cdc6 expression is deregulated in tissues with stratified epithelia. Higher levels of CDC6 protein enhanced the loading of MCM complexes to DNA in epidermal keratinocytes, without affecting their proliferation rate or inducing DNA damage. While Cdc6 overexpression did not promote skin tumors, it facilitated the formation of papillomas in cooperation with mutagenic agents such as DMBA. In addition, the elevated levels of CDC6 protein in the skin extended the resting stage of the hair growth cycle, leading to better fur preservation in older mice.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Current address: Institut Pasteur; Paris, France
Current address: Capricor Therapeutics; San Francisco, CA, USA
Current address: European Molecular Biology Laboratory (EMBL); Heidelberg, Germany
Current address: Roche Farma SA; Madrid, Spain
ISSN:1538-4101
1551-4005
DOI:10.1080/15384101.2015.1120919